J1020 HCPCS code: Injection, methylprednisolone acetate, 20 mg
J1020 is the HCPCS Level II code for injection, methylprednisolone acetate, 20 mg. CMS terminated J1020 on 2024-03-31; do not bill it for later dates of service. In 2024 Medicare paid an average of $4.57 per service for J1020 across 40,745 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. Medicare volume fell 75% from 2022 to 2024 (164,915 to 40,745 services). In 2024, about 3,228 clinicians billed Medicare for J1020 for 19,199 beneficiaries; Illinois, California, Texas accounted for 42% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 2024-04-01 |
| Terminated | 2024-03-31 |
Who bills J1020 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,228 |
| Medicare beneficiaries | 19,199 |
| States with claims | 48 |
| Share of services in top 3 states (Illinois, California, Texas) | 42% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1020, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 164,915 | 62,993 | $3.14 | $2.36 |
| 2023 | 171,141 | 62,155 | $5.60 | $4.31 |
| 2024 | 40,745 | 19,199 | $6.68 | $4.57 |
States with the most J1020 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Illinois | 10,768 | $5.36 |
| California | 3,692 | $5.05 |
| Texas | 2,805 | $3.70 |
| Florida | 2,524 | $4.51 |
| New York | 1,715 | $4.38 |
What changed for J1020
- 1982-01-01: J1020 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1020?
J1020 is the HCPCS Level II code for injection, methylprednisolone acetate, 20 mg. Short descriptor: "Methylprednisolone 20 mg inj".
How much does Medicare pay for J1020?
In 2024, the average Medicare payment was $4.57 per service (average allowed $6.68).
Does Medicare cover J1020?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J10 codes
- J1000 — Injection, depo-estradiol cypionate, up to 5 mg
- J1010 — Injection, methylprednisolone acetate, 1 mg
- J1030 — Injection, methylprednisolone acetate, 40 mg
- J1040 — Injection, methylprednisolone acetate, 80 mg
- J1050 — Injection, medroxyprogesterone acetate, 1 mg
- J1060 — Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070 — Injection, testosterone cypionate, up to 100 mg
- J1071 — Injection, testosterone cypionate, 1 mg
- J1072 — Injection, testosterone cypionate (azmiro), 1 mg
- J1073 — Testosterone pellet, implant, 75 mg
- J1080 — Injection, testosterone cypionate, 1 cc, 200 mg
- J1094 — Injection, dexamethasone acetate, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1020
- Watch J1020 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1020
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.